AzTrials
AzTrials

DeafnessFunSpeechNCT04454255

Benefits of Tablet-based Serious Games to Promote Speech Production in Young Children With Hearing Disabilities

A study testing FunSpeech in people with Deafness and Hearing Loss, run by University Hospital, Geneva at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Learning to speak is a major challenge for children with hearing impairments. Nowadays, special devices such as conventional hearing aids, bone-anchored hearing aids (BAHA) or cochlear implants (CI) allow successful rehabilitation of patients with hearing disabilities. Read more about this study

Who is it for?
Ages Up to 6 years
Conditions the study is for
Deafness, Hearing Loss
What is being tested?
FunSpeech
Could I receive a placebo?
No, everyone receives an active treatment
How many people
13 participants
Where
1 siteSwitzerland
Study dates
1 Mar 2020to 1 Mar 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 6 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Diagnosed with mild to profound hearing loss,
  • Optimum instrumented hearing (hearing aids, BAHA or CI),
  • Language development delay confirmed by a speech therapist,
  • Enough sensorimotor, cognitive and communication skills to play with tablet-based games,
  • French mother tongue

Who cannot join

  • Additional impairments which affect language development or the use of FunSpeech (e.g. motor, orofacial, sensory, cognitive),
  • Refusal of the participant's representative(s) to participate in the study,
  • Refusal of the participant's representative(s) to participate in a modality of the study,
  • If the child/participant refuses to collaborate in two measures of language level.

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Geneva University Hospitals

    Geneva, 1205

Other trials in Switzerland

About this study

Official title: Evaluating the Educational Benefits of Tablet-based Serious Games to Promote Speech Production in Instrumented Young Children With Hearing Disabilities

Learning to speak is a major challenge for children with hearing impairments. Nowadays, special devices such as conventional hearing aids, bone-anchored hearing aids (BAHA) or cochlear implants (CI) allow successful rehabilitation of patients with hearing disabilities. To obtain maximum benefit from these technical aids, instrumented hearing impaired children require specific and intensive speech therapy to compensate for speech development delays. In addition, it is also of primary importance that during daily life (e.g., at home, at school) children are provided with sufficient and good quality auditory stimulation.

The main goal of this project is to encourage speech production with an edutainment tool that can be used at home and that is adapted to the specific needs of young hearing impaired children. For this purpose, the investigators have recently designed an innovative educational solution: FunSpeech, a tablet-based set of video games that respond exclusively to sound and speech. The aim of this serious game is to encourage hearing impaired children to produce controlled sounds in terms of rhythm, intensity, and pitch. These are the main abilities required for controlled speech production. Finally, this serious game aims to support the parents' key role in the speech learning process by offering an effective solution that is easy to use at home with young children.

Being tested
FunSpeech, Control
Keywords
Serious game, Speech development, Speech production, Cochlear implant, Hearing aid, Bone anchored hearing aid
Medical subject headings
Deafness, Hearing Loss

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • FunSpeechBehavioural

    Weekly sessions of regular speech therapy as regularly performed for the individual participant (one hour, once or twice a week) and parent-supervised home use of a serious game. It will be recommended to use FunSpeech every day, 15 minutes per day.

  • ControlBehavioural

    Weekly sessions of regular speech therapy as regularly performed for the individual participant (one hour, once or twice a week).

Study groups in NCT04454255
Study groupRoleWhat they receive
Primo-FunSpeechExperimentalParticipants will begin the study by a period using FunSpeech (45 days) followed by a control period without the game (45 days). This sequence will be repeated once.
Receives: Behavioral: FunSpeech
Primo-controlExperimentalParticipants will begin the study by a control period without the game (45 days) followed by a period using FunSpeech (45 days). This sequence will be repeated once.
Receives: Behavioral: Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Parental inventory (questionnaire) and observation grid of speech production skills completed by the speech therapist.

    Quantitative and qualitative assessments of spoken language level.

    Measured: 6 months

Secondary outcomes (1)
  1. Game usage (total play time, frequency of play sessions, list of games used, gameplay goals achieved)

    This data will be gathered via a tracking system implemented in the game and parental interviews (questionnaires).

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Jul 2020
  2. Study start1 Mar 2020
  3. Primary completion1 Mar 2022
  4. Study completion1 Mar 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Crossover
Model description
Cross-over, repeated-measures, open without masking.
Masking
None (open label)
Enrolment
13 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04454255
Sponsor's protocol ID
ID 2019-02138
Acronym
FunSpeech
Status last verified
Jun 2023
First submitted
5 Mar 2020
Last updated
22 Jun 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing FunSpeech in people with Deafness and Hearing Loss, run by University Hospital, Geneva at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Jun 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Parental inventory (questionnaire) and observation grid of speech production skills completed by the speech therapist. (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jun 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in